Tsvetkov K, Vasileva P, Petkova U
Akush Ginekol (Sofiia). 2007;46 Suppl 2:41-4.
Probiotics are "living organisms that lead to recipient's health benefits when applied in an adequate amount". The purpose is to study the therapeutic effectiveness of the Lactofem preparation (vaginal capsules containing two live strains of lactobacilli and gel) as well as to compare it with that of the classical therapy of bacterial vaginosis (BV) with metronidazole.
Fifty-five female patients with BV were divided into three groups. Group one consisted of 19 patients treated with Flagyl in a dose of 1 g daily for 7 days; group two--of 24 patients with symptomatic BV treated with Lactofem in a dose of 1 capsule and 2 ml of gel every third day for one month, and group three--of 12 patients with asymptomatic BV treated with Lactofem, too.
The therapeutic effect was red two and twelve weeks after its cessation. The patients healed with metronidazole amounted to 63.16% and 42.01% of the cases, respectively. After two weeks, the patients healed with Lactofem amounted to 79.17% and after 12 weeks even to 86.96% of the cases. The patients from group three healed were 83.33% and 100%, respectively.
The independent application of Lactofem leads to better therapeutic effects when compared with the classical treatment of BV with metronidazole. Relapses of BV during the 3-month follow-up after treatment cessation were more seldom encountered.
益生菌是“适量应用时能给宿主带来健康益处的活生物体”。目的是研究Lactofem制剂(含两种乳酸杆菌活菌株的阴道胶囊和凝胶)的治疗效果,并将其与甲硝唑治疗细菌性阴道病(BV)的传统疗法进行比较。
55例BV女性患者分为三组。第一组19例,每日服用1克甲硝唑,共7天;第二组24例有症状的BV患者,每三天使用1粒胶囊和2毫升凝胶的Lactofem治疗一个月;第三组12例无症状的BV患者也用Lactofem治疗。
治疗结束后两周和十二周评估治疗效果。甲硝唑治疗痊愈的患者分别占病例的63.16%和42.01%。两周后,Lactofem治疗痊愈的患者占79.17%,十二周后甚至达到86.96%。第三组患者痊愈率分别为83.33%和100%。
与甲硝唑治疗BV的传统疗法相比,单独应用Lactofem有更好的治疗效果。治疗结束后3个月随访期间,BV复发较少见。